Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • September
  • Page 108
andelyn-to-support-manufacturing-scaleup-for-genprex’s-diabetes-gene-therapy
Posted inGenetics

Andelyn to Support Manufacturing Scaleup for Genprex’s Diabetes Gene Therapy

September 1, 2026
Credit: Laddawan Punna/Getty Images Genprex selected Andelyn Biosciences to support scale-up manufacturing for its diabetes gene therapy program. Its product…
Read More
advanced-imaging-technique-reveals-immune-cell-metabolic-states-in-blood-samples
Posted inGenetics

Advanced Imaging Technique Reveals Immune Cell Metabolic States in Blood Samples

September 1, 2026
Credit: © Guido Vrola - Fotolia.com When a patient is facing certain cancers or an immune condition, clinicians turn to…
Read More
Posted inBiotechnology

From his parents’ basement to your medicine cabinet: Absci CEO endeavors to create biotech’s Apple

September 1, 2026
The overwhelming demand for GLP-1 weight loss drugs has reshaped the drug market, empowering consumers to take charge of their…
Read More
lilly-looks-beyond-obesity-with-up-to-$2.9b-acquisition-of-merida-biosciences
Posted inGenetics

Lilly Looks Beyond Obesity with Up-to-$2.9B Acquisition of Merida Biosciences

September 1, 2026
A Merida Biosciences researcher at work. Eli Lilly has agreed to acquire Merida, a developer of precision therapies for serious…
Read More
Posted inBiotechnology

Is Moderna, Merck’s mRNA cancer vaccine win the start of a ‘personalized medicine revolution’?

September 1, 2026
The announcement from Merck & Co. and Moderna last month that their mRNA cancer vaccine had successfully lengthened patient survival…
Read More
Posted inBiotechnology

Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody

September 1, 2026
Roche is paying oncology-focused Simcere Zaiming $75 million upfront for global rights to a preclinical trispecific antibody targeting B-cell-mediated diseases.
Read More
Posted inBiotechnology

ArsenalBio sheds most of staff in pivot to in vivo CAR-T

September 1, 2026
About a year after halving its staff in a clinical push, Arsenal Biosciences is now making a hard pivot that…
Read More
Posted inBiotechnology

Alumis crushed by midstage lupus flop but plots path to phase 3 for TYK2 inhibitor

September 1, 2026
A phase 2b lupus trial of Alumis’ envudeucitinib has missed its primary and secondary endpoints. But the biotech is still…
Read More
Posted inMedical Technology

Novocure hit by cyberattack exposing patient data

September 1, 2026
Novocure has become the latest medtech company to be hit by a cyberattack, with the oncology specialist revealing that unauthorized…
Read More
Posted inBiotechnology

GSK catches phase 3 fever after mRNA flu vaccine beats standard shots

September 1, 2026
GSK has linked its mRNA seasonal flu vaccine candidate to higher immune responses than conventional jabs in a phase 2…
Read More

Posts pagination

Previous page 1 … 106 107 108 109 Next page

Privacy Policy    Terms

Scroll to Top